Corporate News

Total Voting Rights

31 July 2019

Polarean Imaging plc (AIM: POLX), the medical‑imaging technology company, with a proprietary drug‑device combination product for the magnetic resonance imaging (MRI) market, announces that the total number of shares in issue and total voting rights as at the date of this announcement is 114,438,600 ordinary shares of £0.00037 each.

The total issued share capital of the Company consists of 114,438,600 Ordinary Shares. This number may be used by Shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Polarean Imaging plc	www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer	Via Walbrook PR
Richard Morgan, Chairman

SP Angel Corporate Finance LLP	Tel: +44 (0)20 3470 0470
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)

Walbrook PR	Tel: +44 (0)20 7933 8780 or[email protected]
Paul McManus / Anna Dunphy	Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001